Vanberra Signal

Ridom

Curated by Signal

Developer of software for routine microbial DNA re-sequencing analysis

Overview

Ridom develops software for routine microbial DNA re-sequencing analysis. Ridom software is mainly used for bacterial surveillance in a Public Health setting. Many European National Public Health Agencies such as RKI, RIVM, PHE, SSI as well as CDC, FDA, and numerous worldwide hospitals are among the company's clients. Ridom's lead product is the StaphType software for MRSA. The tool delivers automated quality-controlled curation of a global and public nomenclature. Ridom SpaServer is claimed to be the worldwide largest sequence-based bacterial genotyping database. Ridom has also developed the MIRU-VNTRplus web application for molecular typing of Mycobacterium tuberculosis.

Key facts

Founded
2003
Headquarters
Munster, Germany

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Glucose monitoring system - devices and connected mobile & web apps

    Life Sciences TechnologyPotsdam, Germany
  • Tools for Functional Genomics

    Life Sciences TechnologyGreifswald, Germany
  • Developer of therapeutic vaccines against infectious diseases and cancer

    Life Sciences TechnologyTubingen, Germany

About Ridom

What does Ridom do?

Ridom develops software for routine microbial DNA re-sequencing analysis.

Where is Ridom headquartered?

Ridom is headquartered in Munster, Germany.

When was Ridom founded?

Ridom was founded in 2003.

Which sector is Ridom in?

Ridom operates in Life Sciences Technology.

Who are Ridom's competitors?

Companies similar to Ridom include Emperra, Decodon, and Prime Vector Technologies.